Evidence map›Paper›PMID 29476454›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2019

Isolated cardiac amyloidosis. Utility of bone seeking tracers scintigraphy in differentiating the subtype of amyloid: A case report.

O Bourogianni, E Papadaki, E Foukarakis, S Koukouraki

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

O BourogianniDepartment of Nuclear Medicine, Medical School, University of Crete, Heraklion, Greece. ompourogianni@yahoo.gr.
E PapadakiDepartment of Nuclear Medicine, Medical School, University of Crete, Heraklion, Greece.
E FoukarakisDepartment of Cardiology, Venizeleion General Hospital, Heraklion, Crete, Greece.
S KoukourakiDepartment of Nuclear Medicine, Medical School, University of Crete, Heraklion, Greece.
University of Crete · GRThe General Hospital of Heraklion "Venizeleio-Pananio" · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThree types of amyloid are responsible for cardiac amyloidosis. Differentiation of the subtype is critical for the disease progression and the therapeutic decision.

resultsMyocardial scintigraphy using Tc-PYP is able to differentiate the cardiac amyloid subtype with high sensitivity and specificity. The myocardial uptake of PYP is higher in patients with TTR amyloidosis.

conclusionNon-invasive tests for the detection of cardiac amyloidosis, like myocardial scintigraphy with bone seeking tracers, can play a major role in the diagnosis progression and therapeutic management of patients with cardiac amyloidosis.

Indexed as

Radionuclide ImagingAgedAmyloidAmyloidosisBone and BonesCardiomyopathiesDisease ProgressionHumansMyocardiumRadiopharmaceuticalsSensitivity and SpecificityTechnetium Tc 99m PyrophosphateAmyloidRadiopharmaceuticalsTechnetium Tc 99m Pyrophosphate99mTcHeart failureSPECT

Identifiers

PMID29476454
OpenAlexW2788027206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.